Kilitch Drugs (India) Limited (KILITCH.NS)

INR 317.15

(-1.14%)

Long Term Debt Summary of Kilitch Drugs (India) Limited

  • Kilitch Drugs (India) Limited's latest annual long term debt in 2023 was - INR , down 0.0% from previous year.
  • Kilitch Drugs (India) Limited's latest quarterly long term debt in 2023 FY was - INR , down 0.0% from previous quarter.
  • Kilitch Drugs (India) Limited reported annual long term debt of - INR in 2022, down 0.0% from previous year.
  • Kilitch Drugs (India) Limited reported annual long term debt of - INR in 2021, down 0.0% from previous year.
  • Kilitch Drugs (India) Limited reported quarterly long term debt of - INR for 2023 Q1, down 0.0% from previous quarter.
  • Kilitch Drugs (India) Limited reported quarterly long term debt of - INR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Kilitch Drugs (India) Limited (2023 - 2006)

Historical Annual Long Term Debt of Kilitch Drugs (India) Limited (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 - INR 0.0%
2022 - INR 0.0%
2021 - INR 0.0%
2020 - INR 0.0%
2019 - INR 0.0%
2018 - INR 0.0%
2017 - INR 0.0%
2016 - INR 0.0%
2015 - INR 0.0%
2014 - INR 0.0%
2013 - INR 0.0%
2012 - INR -100.0%
2011 366 Thousand INR -99.93%
2010 530.57 Million INR 23.42%
2009 429.89 Million INR 21.36%
2008 354.24 Million INR -16.96%
2007 426.59 Million INR 115.38%
2006 198.06 Million INR 0.0%

Peer Long Term Debt Comparison of Kilitch Drugs (India) Limited

Name Long Term Debt Long Term Debt Difference
Sigachi Industries Limited 265.79 Million INR 100.0%
Ind-Swift Limited 10.09 Billion INR 100.0%
Bajaj HealthCare Limited 650.34 Million INR 100.0%
Sakar Healthcare Limited 549.55 Million INR 100.0%
Aurobindo Pharma Limited 21.34 Billion INR 100.0%
Innova Captab Limited 2.1 Billion INR 100.0%
Divi's Laboratories Limited 20 Million INR 100.0%
AstraZeneca Pharma India Limited 27.83 Million INR 100.0%
Morepen Laboratories Limited 33.64 Million INR 100.0%
Mankind Pharma Limited 325.81 Million INR 100.0%
Sequent Scientific Limited 1.42 Billion INR 100.0%
Wanbury Limited 820 Million INR 100.0%
Laurus Labs Limited 7.98 Billion INR 100.0%
Nectar Lifesciences Limited 1.4 Billion INR 100.0%
Glenmark Life Sciences Limited 147.61 Million INR 100.0%
Alembic Limited 73.9 Million INR 100.0%
Hikal Limited 4.22 Billion INR 100.0%
Alembic Pharmaceuticals Limited 628.8 Million INR 100.0%
Neuland Laboratories Limited 449.2 Million INR 100.0%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 100.0%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 100.0%
IOL Chemicals and Pharmaceuticals Limited - INR NaN%
Themis Medicare Limited 267.74 Million INR 100.0%
RPG Life Sciences Limited -30.3 Million INR 100.0%
Zydus Lifesciences Limited 251 Million INR 100.0%
Lupin Limited 1.55 Billion INR 100.0%
Amrutanjan Health Care Limited 13.96 Million INR 100.0%
Wockhardt Limited 8.91 Billion INR 100.0%
Vaishali Pharma Limited 35.98 Million INR 100.0%
Aarti Pharmalabs Limited 400 Thousand INR 100.0%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 100.0%
Jubilant Pharmova Limited 31.67 Billion INR 100.0%
FDC Limited 2.46 Million INR 100.0%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 100.0%
Eris Lifesciences Limited 6.54 Billion INR 100.0%
Venus Remedies Limited 386.8 Million INR 100.0%
ZIM Laboratories Limited 356 Million INR 100.0%
Bliss GVS Pharma Limited 355.92 Million INR 100.0%
Par Drugs and Chemicals Limited - INR NaN%
Caplin Point Laboratories Limited 9.2 Million INR 100.0%
Shilpa Medicare Limited 5.6 Billion INR 100.0%
Albert David Limited 6.01 Million INR 100.0%
Ajanta Pharma Limited 235.2 Million INR 100.0%
Hester Biosciences Limited 1.81 Billion INR 100.0%
Suven Pharmaceuticals Limited 212.35 Million INR 100.0%
Solara Active Pharma Sciences Limited 1.17 Billion INR 100.0%
Gufic Biosciences Limited 1.53 Billion INR 100.0%
Windlas Biotech Limited 20.18 Million INR 100.0%
Procter & Gamble Health Limited 68.8 Million INR 100.0%
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR 100.0%
Mangalam Drugs & Organics Limited 133.54 Million INR 100.0%
Granules India Limited 689.71 Million INR 100.0%
Aarti Drugs Limited 2.75 Billion INR 100.0%
Bal Pharma Limited 363.82 Million INR 100.0%
Alkem Laboratories Limited 400 Million INR 100.0%
Sun Pharmaceutical Industries Limited 13.3 Million INR 100.0%
Lincoln Pharmaceuticals Limited - INR NaN%
Medicamen Biotech Limited 12.55 Million INR 100.0%
Unichem Laboratories Limited 382.22 Million INR 100.0%
Bafna Pharmaceuticals Limited 107.53 Million INR 100.0%
Biofil Chemicals and Pharmaceuticals Limited - INR NaN%
Valiant Laboratories Limited 750.89 Million INR 100.0%
Orchid Pharma Limited 1.2 Billion INR 100.0%
Medico Remedies Limited 8.67 Million INR 100.0%
Ind-Swift Laboratories Limited 111.62 Million INR 100.0%
Ipca Laboratories Limited 5.8 Billion INR 100.0%
Brooks Laboratories Limited 3.56 Million INR 100.0%
Syncom Formulations (India) Limited -1.21 Million INR 100.0%
Piramal Enterprises Limited 535.85 Billion INR 100.0%
Torrent Pharmaceuticals Limited 16.04 Billion INR 100.0%
NATCO Pharma Limited 53 Million INR 100.0%
Suven Life Sciences Limited - INR NaN%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 100.0%
Strides Pharma Science Limited 6.71 Billion INR 100.0%
Indoco Remedies Limited 3.51 Billion INR 100.0%
Alpa Laboratories Limited - INR NaN%
Lasa Supergenerics Limited - INR NaN%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 100.0%